Teva Pharmaceutical Industries
TEVA
$16.93
Share price
0.18%
Change (1 day)
135.14%
Change (1 year)
Categories
Teva Pharmaceutical Industries (TEVA) - Cash on Hand
Cash on Hand as of March 2024 : $2.99 B
According to Teva Pharmaceutical Industries's latest financial reports the company has $2.99 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Teva Pharmaceutical Industries - Cash on Hand chart (from 2001 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $3.22 B | 15.17% |
| 2022-12-31 | $2.80 B | 29.38% |
| 2021-12-31 | $2.16 B | -0.55% |
| 2020-12-31 | $2.17 B | 10.23% |
| 2019-12-31 | $1.97 B | 10.83% |
| 2018-12-31 | $1.78 B | 85.05% |
| 2017-12-31 | $0.96 B | -2.53% |
| 2016-12-31 | $0.98 B | -85.78% |
| 2015-12-31 | $6.94 B | 212.04% |
| 2014-12-31 | $2.22 B | 114.45% |
| 2013-12-31 | $1.03 B | -63.95% |
| 2012-12-31 | $2.87 B | 162.68% |
| 2011-12-31 | $1.09 B | -14.64% |
| 2010-12-31 | $1.28 B | -42.88% |
| 2009-12-31 | $2.24 B | 17.88% |
| 2008-12-31 | $1.90 B | -33.67% |
| 2007-12-31 | $2.87 B | 40.66% |
| 2006-12-31 | $2.04 B | -7.59% |
| 2005-12-31 | $2.21 B | 112.49% |
| 2004-12-31 | $1.04 B | -24.53% |
| 2003-12-31 | $1.37 B | 31.92% |
| 2002-12-31 | $1.04 B | 32.33% |
| 2001-12-31 | $0.79 B |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $9.69 B | 224.11% | 🇨🇭 Switzerland |
 Pfizer PFE | $11.92 B | 298.83% | 🇺🇸 USA |
 Sanofi SNY | $9.92 B | 231.93% | 🇫🇷 France |
 Merck MRK | $5.61 B | 87.86% | 🇺🇸 USA |
 AstraZeneca AZN | $8.02 B | 168.17% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $5.17 B | 73.02% | 🇬🇧 UK |
 Dr. Reddy's RDY | $0.86 B | -70.94% | 🇮🇳 India |